Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Many physicians have encountered one or more serious or potentially dangerous patients over the years, and according to Medscape research, patient trust has declined.
Read Full NewsIn a post hoc analysis of 2 phase 3 trials, AD109 reduced hypoxic burden by 69.8% vs 20.0% with placebo in postmenopausal women with OSA.
Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD
2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics
Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD
Kiril Kiprovski, MD, clinical professor of neurology and director of the Division of Neuromuscular Medicine at NYU Langone, reviews the clinical clues, bedside tests, and referral considerations that help eye care clinicians identify Lambert-Eaton myasthenic syndrome in patients with fluctuating ptosis or diplopia.
The 500-participant study will assess whether pridopidine, an investigational sigma-1 receptor agonist, can slow functional decline and improve survival in patients with early, rapidly progressing amyotrophic lateral sclerosis.
1.
Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.
2.
Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis
3.
Can 80 Gy Radiation Boost Survival in Prostate Cancer?
4.
In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?
5.
Research discovery halts childhood brain tumor before it forms
1.
Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics
2.
Exploring the Latest Advances in PTLD Cancer Treatment
3.
Bispecific Immune Engagers for Solid Tumors: Mechanisms, Clinical Evidence, and Future Directions
4.
Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies
5.
Understanding Neutropenic Fever: What It Is and Why it's a Serious Concern
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
2.
Screening for Red Cell Membrane Disorders Through Ektacytometry-Based Deformability Profiling
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
5.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge